Nelson Capital Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$780K Sell
2,154
-12,070
-85% -$4.13M 0.09% 74
2026
Q1
$5M Sell
14,224
-302
-2% -$108K 0.61% 27
2025
Q4
$4.75M Sell
14,526
-389
-3% -$123K 0.56% 33
2025
Q3
$4.21M Sell
14,915
-90
-0.6% -$26.1K 0.5% 37
2025
Q2
$4.19M Buy
15,005
+282
+2% +$79.9K 0.55% 37
2025
Q1
$4.59M Sell
14,723
-279
-2% -$82.4K 0.79% 32
2024
Q4
$3.91M Sell
15,002
-1,797
-11% -$533K 0.65% 36
2024
Q3
$5.41M Sell
16,799
-1,351
-7% -$442K 0.91% 27
2024
Q2
$5.67M Sell
18,150
-504
-3% -$148K 1.01% 25
2024
Q1
$5.3M Buy
18,654
+2,901
+18% +$849K 1.01% 28
2023
Q4
$4.54M Sell
15,753
-2,672
-15% -$728K 1.02% 29
2023
Q3
$4.95M Sell
18,425
-46
-0.2% -$11.5K 1.21% 25
2023
Q2
$4.1M Buy
18,471
+217
+1% +$50.4K 1.06% 31
2023
Q1
$4.41M Buy
18,254
+557
+3% +$137K 1.25% 30
2022
Q4
$4.65M Buy
17,697
+15,025
+562% +$4.03M 1.36% 30
2022
Q3
$602K Hold
2,672
0.18% 78
2022
Q2
$650K Sell
2,672
-75
-3% -$18.4K 0.18% 75
2022
Q1
$664K Buy
2,747
+37
+1% +$8.5K 0.13% 79
2021
Q4
$610K Hold
2,710
0.11% 82
2021
Q3
$576K Sell
2,710
-87
-3% -$20K 0.11% 79
2021
Q2
$682K Hold
2,797
0.14% 76
2021
Q1
$696K Hold
2,797
0.15% 73
2020
Q4
$643K Sell
2,797
-49
-2% -$11.3K 0.14% 70
2020
Q3
$723K Sell
2,846
-250
-8% -$61.9K 0.13% 73
2020
Q2
$730K Hold
3,096
0.16% 68
2020
Q1
$628K Buy
3,096
+400
+15% +$87.4K 0.17% 66
2019
Q4
$650K Sell
2,696
-300
-10% -$66.1K 0.14% 74
2019
Q3
$580K Buy
2,996
+275
+10% +$52.8K 0.14% 66
2019
Q2
$501K Buy
2,721
+49
+2% +$8.77K 0.12% 69
2019
Q1
$508K Buy
2,672
+217
+9% +$41.4K 0.13% 67
2018
Q4
$478K Hold
2,455
0.13% 70
2018
Q3
$509K Hold
2,455
0.12% 66
2018
Q2
$453K Buy
2,455
+63
+3% +$11.1K 0.12% 67
2018
Q1
$408K Sell
2,392
-715
-23% -$131K 0.11% 73
2017
Q4
$540K Buy
3,107
+2,330
+300% +$412K 0.17% 63
2017
Q3
$145K Sell
777
-123
-14% -$21.8K 0.05% 94
2017
Q2
$155K Buy
900
+160
+22% +$26K 0.05% 95
2017
Q1
$121K Buy
+740
New +$123K 0.04% 99
2016
Q4
Sell
-740
Closed -$123K 253
2016
Q3
$123K Buy
+740
New +$125K 0.04% 96
2016
Q2
Sell
-320
Closed -$48K 269
2016
Q1
$48K Sell
320
-35
-10% -$5.2K 0.02% 109
2015
Q4
$58K Hold
355
0.02% 101
2015
Q3
$49K Hold
355
0.02% 109
2015
Q2
$54K Hold
355
0.02% 114
2015
Q1
$57K Hold
355
0.02% 110
2014
Q4
$57K Hold
355
0.02% 118
2014
Q3
$50K Buy
355
+5
+1% +$653 0.02% 123
2014
Q2
$41K Buy
350
+160
+84% +$18.5K 0.02% 126
2014
Q1
$23K Buy
190
+80
+73% +$9.7K 0.01% 150
2013
Q4
$13K Hold
110
0.01% 168
2013
Q3
$12K Hold
110
0.01% 169
2013
Q2
$11K Buy
+110
New +$11.4K 0.01% 173

Other funds holding AMGN

Nelson Capital Management's AMGN Position: Q2 2026 in Review

Nelson Capital Management reduced its Amgen (AMGN) stake by 85% in Q2 2026, selling an estimated $4.13M and leaving 2,154 shares worth $780K. The position accounts for 0.09% of the portfolio, ranked #74.

Nelson Capital Management first reported a position in AMGN in Q2 2013 and has held it in 51 quarters since. The position peaked at $5.67M in Q2 2024. 1,279 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Nelson Capital Management held 2,154 shares of Amgen worth $780K as of Q2 2026.
  • Nelson Capital Management sold 12,070 Amgen shares in Q2 2026, an estimated $4.13M.
  • Amgen made up 0.09% of Nelson Capital Management's portfolio in Q2 2026, its #74 holding.
  • Nelson Capital Management first reported a position in Amgen in Q2 2013 and has held it in 51 quarters since.
  • Nelson Capital Management's Amgen position peaked at $5.67M in Q2 2024.
  • 1,279 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Nelson Capital Management's 13F filing for Q2 2026, filed 24 Jul 2026.